September 7, 2018—BD (Becton, Dickinson and Company) announced that is has received FDA approval for the 220-mm length of its Lutonix 035 drug-coated balloon (DCB) for the treatment of long superficial femoral artery (SFA) lesions in patients with peripheral artery disease (PAD).
“The new longer lengths of the Lutonix 035 DCB represent a tremendous opportunity for physicians to enhance their PAD treatment in long lesions with a proven technology that will now require fewer DCBs and fewer inflations, reducing DCB healthcare expenditures overall,” commented vascular surgeon Chad Laurich, MD, in the company's announcement.
BD noted that in the Lutonix Global SFA Real-World Registry, 22% of the femoropopliteal lesions were longer than 150 mm. In some of these patients, multiple DCBs were used to cover the length of the long lesion. With the approval of the 220-mm device, more disease can be treated with a single Lutonix 035 DCB.
advertisement
Related Articles
Acute Thrombus of the Inferior Vena Cava Extending to the Femoral Veins
By Moderators: Ido Weinberg, MD; and Robert M. Schainfeld, DO, FSVM, FSCAI
Panel: Annemarie E. Fogerty, MD; Robert M. Schainfeld, DO, FSVM, FSCAI; and Mitchell D. Weinberg, MD, MBA
Top 5 Articles From August 2018
Emerging Tools for Lytic-Free, Single-Session Treatment of Venous Thromboembolic Disease
The ClotTriever Outcomes (CLOUT) registry principal investigators share their current DVT practices and thoughts on the new study, and DVT and PE case reports are presented using the Inari Medical ClotTriever and FlowTriever Systems.
With Robert E. Beasley, MD, FSIR, FSCAI; William Marston, MD; Suman Annambhotla, MD; and Wissam A. Jaber, MD
Left Superficial Femoral Artery Occlusion in a Patient With an Aortobifemoral Graft
By Moderator: Ehrin J. Armstrong, MD
Panel: Steve Henao, MD, FACC, FACS; Sahil A. Parikh, MD, FACC, FSCAI; and Saher Sabri, MD, FSIR
Incidental Splenic Artery Aneurysm on CT Imaging
By Moderator: Paul J. Rochon, MD, FSIR
Panel: Vishal Kumar, MD; Kumar Madassery, MD; and Waleska M. Pabon-Ramos, MD, MPH, FSIR
Carotid Occlusion With Middle Cerebral Artery Thrombus
By Moderators: Adnan H. Siddiqui, MD, PhD; and Kunal Vakharia, MD;
Panel: Ansaar T. Rai, MD, MBA; and Aquilla S. Turk, DO
Treatment Algorithm: How DCB Evidence Has Changed My Practice
With Marcus Treitl, MD, MBA, EBIR
Top 5 from CIToday's Current Issue
Transcatheter Chordal Repair for Degenerative Mitral Regurgitation
Current and future directions of therapeutic options for patients with degenerative MR.
By Andrea Colli, MD, PhD; Alessandro Fiocco, MD; Nicola Pradegan, MD; Matteo Nadali, MD; Laura Besola, MD; Eleonora Bizzotto, MD; and Gino Gerosa, MD
An Update on Transcatheter Tricuspid Valve Therapies
A review of the current state of transcatheter tricuspid valve therapies and where they are headed next.
By Antonio Mangieri, MD; Giorgios Tzanis, MD; and Azeem Latib, MD
Transcatheter Leaflet Repair for Functional MR
What will randomized trials mean for the future of mitral intervention?
By Ted Feldman, MD, FESC, FACC, MSCAI; Paul Sorajja, MD, FACC, FSCAI; Paul Grayburn, MD, FACC, FSCAI; and Francesco Maisano, MD
Clinical Data for Stenting High-Risk Patients Requiring Short DAPT
Discussing the clinical benefits of the COBRA PzF NanoCoated Coronary Stent (NCS).
With Gilles Montalescot, MD, PhD; Axel de Labriolle, MD, PhD; and Donald Cutlip, MD
State of the Art of Transcatheter Mitral Annuloplasty: Present and Future
An appraisal of current and upcoming devices for direct and indirect transcatheter annuloplasty procedures.
